Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...
BACKGROUND In acute asthma the optimal duration of treatment with combination β agonist and anticholinergic nebuliser solutions is unknown; most studies have investigated single doses or treatment for ...
Department of Membrane Transport and Biopharmaceutics, Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan, and Preclinical ...
The majority of deaths in COPD are from cardiovascular causes. Several large randomized controlled trials demonstrate that inhaled anticholinergic agents ipratropium and tiotropium increase the risk ...
The half-life of a steroid drug affects how long it stays in your body. Oral steroids can cause more side effects than inhaled steroids. How long steroids for asthma stay in your system depends on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback